A Newport Beach-beach based startup drug maker founded by the former chief of urology at Hoag Memorial Hospital Presbyterian has seen a growth spurt for its offering in the field of sexual medicine.

An over-the-counter, FDA-approved treatment for "PE"—that's premature ejaculation, for those who aren't up to date on their pharmaceutical acronyms—is beginning clinical trials this month at Kaiser in ...

Call it the anti-Viagra. It's not a product for the man who can't get the party started. It's for the man who ends the party too soon. Competition is heating up to treat premature ejaculation, or PE, ...

Since 2010, Jeff Abraham has had a stake in Promescent, an over-the-counter spray intended to help men overcome premature ejaculation. He invested $100,000 and wrote business plans for the company ...

Known as anti-Viagra, a new drug which treats premature ejaculation could be the next big thing. Promescent, an FDA-approved medication to prevent premature ejaculation, is revolutionising treatment ...

Premature ejaculation is a form of male sexual dysfunction. From the point of view of the man and his sexual partner, premature ejaculation means the man having an orgasm or ‘climaxing’ sooner than ...